Published in AIDS Res Hum Retroviruses on January 01, 1994
Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest (2000) 1.07
Early physiological abnormalities after simian immunodeficiency virus infection. Proc Natl Acad Sci U S A (1998) 1.01
Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. J Virol (1998) 0.98
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81
Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med (1996) 5.63
Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96
Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol (2000) 3.48
Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol (1989) 3.43
Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol (2000) 3.31
Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat Med (1997) 3.11
A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell (1995) 3.03
HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med (1999) 3.01
Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med (2001) 2.90
The mucosal immune system: primary target for HIV infection and AIDS. Trends Immunol (2001) 2.38
Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol (1990) 1.97
Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol (1989) 1.88
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86
Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey. J Virol (1991) 1.82
Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am J Pathol (1992) 1.76
Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. Clin Immunol Immunopathol (1997) 1.74
Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol (1996) 1.67
Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J Neurovirol (1998) 1.65
Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia (2001) 1.56
Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol (1992) 1.54
Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J Neurovirol (1996) 1.50
Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther (1997) 1.50
Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol (1999) 1.42
Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses. J Virol (1999) 1.41
Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med (1998) 1.39
Identification of an Enterocytozoon bieneusi-like microsporidian parasite in simian-immunodeficiency-virus-inoculated macaques with hepatobiliary disease. Am J Pathol (1997) 1.38
Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J Virol (2001) 1.38
The non-human primate model of tuberculosis. J Med Primatol (2012) 1.37
Monitoring alpha4beta7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection. Mucosal Immunol (2009) 1.37
The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J Virol (1994) 1.36
Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am J Pathol (1992) 1.32
Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J Med Primatol (1995) 1.32
Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J Immunol (1999) 1.31
Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection. J Virol (2001) 1.27
Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates. J Med Primatol (1992) 1.26
IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol (2012) 1.26
Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J Med Primatol (1992) 1.26
Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus. J Virol (2000) 1.25
Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys. AIDS Res Hum Retroviruses (1999) 1.24
Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine. J Virol (1986) 1.24
Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239. Am J Pathol (1996) 1.22
Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. Blood (2001) 1.21
Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J Exp Med (2000) 1.18
Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol (1998) 1.18
Early brain injury in the SIV-macaque model of AIDS. AIDS (2000) 1.17
Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol (1997) 1.17
Requirements for lymphocyte activation by unusual strains of simian immunodeficiency virus. J Virol (1996) 1.12
Localization of persistent Enterocytozoon bieneusi infection in normal rhesus macaques (Macaca mulatta) to the hepatobiliary tree. J Clin Microbiol (1998) 1.10
The gastrointestinal tract and the pathogenesis of AIDS. AIDS (1998) 1.08
Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus. Lab Invest (1995) 1.08
Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements. J Virol (1997) 1.07
Neuropathogenesis of simian immunodeficiency virus infection in macaque monkeys. J Neurovirol (1997) 1.06
Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques. Am J Pathol (2000) 1.05
Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther (1995) 1.04
Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J Neuroimmunol (2002) 1.03
Enterocytozoon bieneusi as a cause of proliferative serositis in simian immunodeficiency virus-infected immunodeficient macaques (Macaca mulatta). Arch Pathol Lab Med (2000) 1.02
Evidence of horizontal transmission of Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J Infect Dis (1993) 1.01
Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther (1994) 1.01
Mechanisms associated with thymocyte apoptosis induced by simian immunodeficiency virus. J Immunol (2000) 1.01
Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation (2000) 0.99
Simian immunodeficiency virus-inoculated macaques acquire Mycobacterium avium from potable water during AIDS. J Infect Dis (1997) 0.98
Induction of simian acquired immune deficiency syndrome (SAIDS) with a molecular clone of a type D SAIDS retrovirus. J Virol (1987) 0.98
Neuropathogenesis of simian immunodeficiency virus in neonatal rhesus macaques. Am J Pathol (1999) 0.97
Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS. Am J Pathol (1999) 0.96
Enteropathogenic Escherichia coli and ulcerative colitis in cotton-top tamarins (Saguinus oedipus). J Infect Dis (2001) 0.96
Simian AIDS ELISA: sensitivity, specificity and predictive values based on a comparison with Western blot technique. Lab Anim Sci (1988) 0.95
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther (1996) 0.95
Mycobacterium avium complex in macaques with AIDS is associated with a specific strain of simian immunodeficiency virus and prolonged survival after primary infection. J Infect Dis (1995) 0.95
Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation. Am J Pathol (2001) 0.95
Identification of enteropathogenic Escherichia coli in simian immunodeficiency virus-infected infant and adult rhesus macaques. J Clin Microbiol (2001) 0.93
Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Cancer Gene Ther (2007) 0.93
Magnetic resonance spectroscopy: an in vivo tool for monitoring cerebral injury in SIV-infected macaques. J Med Primatol (2002) 0.92
Empty capsids in column-purified recombinant adenovirus preparations. Hum Gene Ther (2001) 0.91
VCAM-1 expression and leukocyte trafficking to the CNS occur early in infection with pathogenic isolates of SIV. J Med Primatol (1995) 0.91
Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo. Am J Pathol (1991) 0.90
Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero. Am J Pathol (1996) 0.89
p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. Clin Cancer Res (1998) 0.88
Detection of simian immunodeficiency virus RNA from infected rhesus macaques by the polymerase chain reaction. J Virol Methods (1992) 0.88
Chronic immune stimulation accelerates SIV-induced disease progression. J Med Primatol (2001) 0.88
Rhesus macaque brain microvessel endothelial cells behave in a manner phenotypically distinct from umbilical vein endothelial cells. J Neuroimmunol (2001) 0.88
S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS. Neuropathol Appl Neurobiol (2012) 0.87
Quantitative evaluation of Enterocytozoon bieneusi infection in simian immunodeficiency virus-infected rhesus monkeys. J Med Primatol (2003) 0.87
Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J Virol (2001) 0.86
Simian immunodeficiency virus disrupts extended lengths of the blood--brain barrier. J Med Primatol (2005) 0.86
Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer (1996) 0.86
Characterization of the cutaneous exanthem in macaques infected with a Nef gene variant of SIVmac239. J Invest Dermatol (1998) 0.84
Activation of the blood-brain barrier by SIV (simian immunodeficiency virus) requires cell-associated virus and is not restricted to endothelial cell activation. Biochem Soc Trans (2004) 0.83
Expression of serotonin transporters by peripheral blood mononuclear cells of rhesus monkeys (Macaca mulatta). Cell Immunol (2007) 0.83
Pulmonary cryptosporidiosis in simian immunodeficiency virus-infected rhesus macaques. Vet Pathol (2000) 0.83
Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium. Gene Ther (2001) 0.81
Proliferative potential of canine oral epulides and malignant neoplasms assessed by bromodeoxyuridine labeling. Vet Pathol (1999) 0.81
Evaluation of anti-human antibodies for immunohistochemistry on archival nonhuman primate tissues. J Med Primatol (1996) 0.80
A case of pulmonary cestodiasis in a simian immunodeficiency virus-infected pigtailed macaque (Macaca nemestrina) in which virus-infected leukocytes are present within the lesion. J Med Primatol (1996) 0.80
Quantitative image analysis of simian immunodeficiency virus replication in macrophages coinfected with Mycobacterium avium complex. J Infect Dis (2000) 0.80
Oral immunization studies with Streptococcus mutans and influenza vaccines in rhesus macaque monkeys. Adv Exp Med Biol (1995) 0.79
Nodular Pneumocystis carinii pneumonia in SIV-infected macaques. Vet Pathol (1999) 0.79
Effects of sex, age, puncture site, and blood contamination on the clinical chemistry of cerebrospinal fluid in rhesus macaques (Macaca mulatta). Am J Vet Res (1993) 0.78